{
    "prompt": "\n    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n    {\n        \"Status\": \"no_match\",\n        \"Message\": \"No drugs are FDA-approved for the provided context\"\n    }\n    \n    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n    {\n        \"Status\": \"success\",\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\": \n            \"FDA-approval status\":\n            \"Link to FDA-approved Label\":\n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0020791\nAge: 62\nGender: Female\nSample ID: P-0020791-T01-IM6\nGene Panel: IMPACT468\nCancer Type: Colon Adenocarcinoma\nSample Type: Metastasis\nTumor Purity: 60.0%\n=============\nDNA Variants:\nAPC c.847C>T (p.R283*) - in 46.00% of 697 reads\nBRCA2 c.8524C>T (p.R2842C) - in 19.00% of 420 reads\nKRAS c.35G>T (p.G12V) - in 33.00% of 625 reads\nPIK3CA c.1624G>A (p.E542K) - in 37.00% of 533 reads\nPPP2R1A c.547C>T (p.R183W) - in 39.00% of 869 reads\nSMAD2 c.1285C>T (p.Q429*) - in 55.00% of 266 reads\nSMAD3 c.799G>T (p.E267*) - in 70.00% of 858 reads\nCNA Data:\nNo CNA data found.\nStructural Variants:\nAPC - nan (DELETION)\n    ",
    "response": "{\n  \"Status\": \"no_match\",\n  \"Message\": \"No drugs are FDA-approved for the provided context\"\n}"
}